Aims/hypotheses. In adults, type 2 diabetes and obesity have been associated with structural brain changes, even in the absence of dementia. Some evidence suggested similar changes in adolescents with type 2 diabetes but comparisons with a non-obese control group have been lacking. The aim of the current study was to examine differences in microstructure of gray and white matter between adolescents with type 2 diabetes, obese adolescents and healthy weight adolescents.
Introduction
There has been a marked world-wide increase in the prevalence of type 2 diabetes The exact extent and location of gray and white matter differences in adolescents with type 2 diabetes requires further examination using more accurate and impartial techniques, such as systematic voxel-wise mapping across the entire cortex and comparison across obese, type 2 diabetic and normal weight adolescents. The aim of this study was to examine whether type 2 diabetes and obesity are complementary or independent correlates of structural brain differences observed in adolescents with type 2 diabetes. Moreover, as FA is the combined measure of both radial and axial diffusion, which are often suggested to indicate demyelination and axonal degeneration respectively (Wozniak & Lim, 2006), we examined the composites of FA independently.
Methods

Participants
Fifteen adolescents with type 2 diabetes, 21 obese and 22 control adolescents participated (see Table 1 ). All adolescents with type 2 diabetes were referred to the study by collaborating paediatric endocrinologists in the Midlands and North-West of England. Obese
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6 adolescents were either referred by dieticians or responded to study advertisements; control participants were recruited from local schools. Recruitment took place from November 2010 -October 2012.
Selection criteria included: (1) aged between 12-18 years, (2) being able to understand and read English and (3) being diagnosed for at least 6 months (for the type 2 diabetes group).
Each adolescent's BMI was converted to a Z score (SD-BMI) based on the British 1990 growth reference for height, weight, and body mass index (Cole et al., 1995 Centre.
Procedure and Measures
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A C C E P T E D M A N U S C R I P T mm. A subset of participants were scanned using a diffusion sequence employing echo planar imaging (75 slices with isotropic 2 × 2 × 2 mm3 voxels, TR = 9,360 ms, TE = 77.8 ms).
Diffusion data was acquired in 61 gradient directions with a b value of 1,500 s/mm2, and 1 volume was acquired with no diffusion weighting (b = 0 image).
Image processing
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We used VBM to examine structural differences in gray matter between the three groups. Pre-processing of the T1-weighted images was done using SPM8 Within the same generative model (Ashburner & Friston, 2005 ) all T1-weighted images were segmented and the tissue segments normalized to the customised TPM using an affine transformation. These images were then used to create a study specific template using the Diffeomorphic Anatomical Registration Through Exponentiated Lie algebra (DARTEL) registration method (Ashburner, 2007) . All T1 weighted images were then segmented based on the previously estimated segmentation parameters, spatially normalized to the study specific template and corrected for bias-field inhomogeneities using the unified algorithm in VBM8 toolbox Ashburner & Friston, 2005) . Non-linear only normalization to the study specific template was used to account for individual brain sizes. The gray matter (GM) segmented images were then smoothed with 6x6x6 mm Gaussian kernel.
Between-group differences in GM volume were assessed in SPM8 using one-way ANOVA for three independent groups controlling for age and gender. For each contrast, statistical parametric maps were computed on a voxel by voxel basis to test for morphological differences between groups. In agreement with previous VBM studies for whole-brain
analysis, clusters were considered significant at the threshold of P<0.001, using an extent threshold of 200 contiguous voxels. This level is in agreement with published standards for applying VBM when there are priori hypotheses for regional differences (Ashburner et al., 2003) .
Tract based spatial statistics (TBSS) were used to assess group differences in fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD). All diffusion data was analysed using FMRIB Software Library (FSL, Oxford, UK; Smith et al., 2004).
First, the eddy current correction tool was used to align all diffusion volumes to the no diffusion volume using affine registration. A binary brain mask was created from the non- conducting a one-way ANOVA followed by Bonferroni correction for multiple comparisons.
Results
Sample characteristics
As expected, participants with type 2 diabetes had significantly higher blood glucose, HbA1c, c-peptide and fasting insulin than controls and obese participants (see Table 1 ). Six participants in the obese group met the WHO diagnostic criteria (World Health Organisation, 2006) of impaired glucose tolerance (IGT; fasting plasma glucose < 7.0mmol/l and 2-h plasma glucose after OGTT of ≥ 7.8 and <11.1mmol/l); none of the obese participants had diabetes. There was a significant difference in age in the VBM sub-set, however age was controlled for in all analyses. Note that the analyses below were also performed without the male participants and results were compared to findings reported below. No qualitative differences were found, suggesting that gender effects do not drive our results.
VBM results
There were significant differences between GM volumes between the groups.
Participants with type 2 diabetes showed smaller GM volume in the caudate and putamen
bilaterally than the control participants ( Figure 1a , Table 2 ). The obese participants showed smaller GM volume in the right hippocampus, left putamen, left caudate and amygdala bilaterally than the control participants (Figure 1b Table 2 ). Controls had greater GM volume in putamen and caudate bilaterally, left amygdala and left thalamus than the other two groups together. (Figure 1c , Table 2 ) and there were no areas where controls had lower GM volume than the other groups. There were no significant differences between obese and type 2 diabetes participants.
To understand the relationship between lower GM volumes and the clinical variables, GM density values were extracted from each area showing difference (Suppl. Table 1 ). Bivariate correlations showed that lower GM density was associated with higher BMI in all regions showing significant differences in GM density between the control participants and the obese and T2DM participants with the exception of the right caudate (p >.09). After Bonferroni adjustment BMI remained significantly associated with GM density in the left caudate, left amygdala and left hippocampus. HbA1c correlated positively with GM density in the right hippocampus only, but not when only the control-and obese participants were considered (Suppl. Table 1) indicating, as expected, that group membership and HbA1c were not fully independent of each other. When considering only the control-and obese participants, the correlations between HOMA-IR and GM density in the left amygdala and hippocampus were significant (See Suppl. Figure 1 ), although these were not significant when the diabetes group was included (after Bonferoni adjustment). When these variables were entered into a forward regression model while additionally controlling for age, it was found that BMI-SD was the only independent predictor of GM density explaining 42.3% of the variance in GM density in the amygdala (β = -0.708; p< .0001) and 41.9% of the variance in GM density in the left hippocampus (β = -0.706; p<.0001). Moreover, GM abnormalities were not more prominent in obese adolescents with impaired glucose tolerance but without type 2 diabetes (Wilks' λ ACCEPTED MANUSCRIPT Regions of reduced FA in the type 2 diabetes group were mainly driven by a significant increase in radial diffusivity (p=.008 control vs. T2DM). The mean, radial or axial diffusivity of obese participants did not differ from the control or type 2 diabetes participants.
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Moreover, there was no difference in the mean diffusivity and axial diffusivity values between the three groups ( Figure 3 ). Radial diffusivity was positively correlated with BMI (r = .300; p= .045), HbA1c (r = .414; p= .008), and HOMA-IR (r = .341; p= .042), but when these variables were entered into a forward regression model while additionally controlling for age, none were independent predictors of radial diffusivity. WM abnormalities were not more prominent in obese adolescents with impaired glucose tolerance but without type 2 diabetes compared to their obese counterparts with normal glucose tolerance (Wilks' λ = .861,
Neither FA nor any of the diffusivity measures were significantly associated with the duration of diabetes (all p's > .38).
Discussion
Both adolescents with type 2 diabetes and obese adolescents had reduced GM volume compared with healthy weight adolescents in a range of medial brain regions. There was no difference in GM volume between the adolescents with type 2 diabetes and obesity. We also found reduced FA in adolescents with type 2 diabetes compared to the normal weight control participants in a range of central brain areas, and these reductions were best explained by increases in radial diffusivity.
To date, only two other studies examined structural brain abnormalities in adolescents FA is frequently used to refer to white matter 'integrity' but is only one of several indicators; we examined other diffusivity parameters to provide a more detailed picture of the underlying microstructural WM differences. Our data suggests that the reduction in FA in the adolescents with type 2 diabetes stemmed from an increased diffusivity in the radial axis, indicate that type 2 diabetes, especially at a younger age, is associated with increased radial, but not axial diffusivity, which is suggestive of demyelination rather than atrophy, but that with advancing age the risk of WM atrophy may also increase.
We did not find a difference in WM between participants with type 2 diabetes and obese participants or between obese and control participants. The relationship between obesity and WM abnormalities both in adolescents and adults has been the topic of several It is important to note though that the obese group in the present study included participants with impaired glucose tolerance, which may go some way in explaining that the WM structure of the obese group were in-between the diabetes group and control group. This is in line with Weinstein et al. (2015) who, in a study including young and middle-aged adults, found a dose-dependent relationship between brain integrity (defined by principle component analysis on FA and GM density measures) and categories of fasting blood glucose (normal glucose metabolism, impaired glucose metabolism and type 2 diabetes) with highest levels of brain integrity in people with normal glucose metabolism. However, in the current study WM abnormalities were not more prominent in obese adolescents with impaired glucose tolerance but without type 2 diabetes compared to their obese counterparts with normal glucose tolerance. It is of note that glucose tolerance is a biological continuum with artificial cut-offs to define normal glucose metabolism, impaired glucose tolerance and diabetes separated by
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17 small margins (7.8mmol/L to 11.1mmol/L for instance). As only six of the obese participants met the criteria for impaired glucose tolerance further studies with larger samples are needed to disentangle the effects of obesity, impaired glucose tolerance and type 2 diabetes on WM structure in young people.
The underlying mechanisms of the structural abnormalities in adolescents with type 2 diabetes are unknown and causal inferences cannot be made based on the present data, but a number of possible causes can be speculated. First, the GM and WM abnormalities in the brains of adolescents with type 2 diabetes or obesity could signify a delay in normal A strength of the current study is that we used objective automatic quantitative volumetric brain imaging techniques over the whole brain instead of focussing on a-priori set brain regions. Although this may have reduced the power of finding differences between the groups compared to ROI analyses, our findings are likely to be robust to find differences in FA between healthy weight adolescents and those with type 2 diabetes. This is the first study to use a study specific brain template to examine WM and GM abnormalities comparing adolescents with type 2 diabetes, those with obesity and healthy weight with objective techniques such as VBM and TBSS. Finally, participants came from clinics and schools from a large geographical region and major ethnic and social groupings were represented.
However, our study also has limitations. First, the sample sizes were relatively small for a structural study, which may have reduced the power of finding WM differences between the obese group and the type 2 diabetes groups and between the obese and control groups.
Second, the current study did not include assessment of cognitive function. Type processing speed, which, in turn, may affect cognitive function. However, all our participants were attending secondary schools or college at the appropriate level for their age suggesting that if cognitive deficits were present, they were likely to be mild to very mild. Future studies should examine whether the abnormalities in WM and GM found in this study result in reduced cognitive abilities. Third, as discussed above, the obese group in the present study included participants with impaired glucose tolerance, which may have affected the WM results.
Conclusions
Type 2 diabetes, even in adolescents, is associated with differences in white matter microstructure as indicated by lower FA in a large number of commissural, association and projection pathways. FA reductions were explained by increases in radial diffusivity, consistent with demyelination of white matter tracts. Compared to healthy weight controls, adolescents with type 2 diabetes and those with obesity also show reduced GM. It is currently unknown whether the abnormalities in GM and WM in adolescents with type 2 diabetes or obesity are reversible. Given the potentially serious consequences for these young people, longitudinal studies are now needed. 
A C C E P T E D
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
Contribution Statement
AN, HA, SH, JB, TB conceived and designed the study, contributed to data analysis and interpretation; AC and MC performed data analysis and interpretation, MC and HA made substantial contributions to data interpretation, and reviewed and revised the manuscript; SH, JB and TB reviewed and revised the manuscript; AN wrote and revised the manuscript and had overall responsibility for the integrity of the work as a whole. All authors approved the
final version of the article. 
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T A C C E P T E D
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A C C E P T E D M A N U S C R I P T 33 obese adolescents than controls (MNI co-ordinates x=-21.4, y=-5.6, z=-20.7), (c) type 2 diabetes and obese adolescents than controls (MNI co-ordinates x=--18, y=13.8, z=-2).
Overlaid on an age and gender specific paediatric template created using TOM8 toolbox in SPM8. The left side of the image corresponds to the left hemisphere of the brain. 
